Drug intelligence / Profile preview

p1075

Development stage
Unknown
Modality
Small Molecules
01

Overview

P1075 is a small molecule vasodilator classified as an ATP-sensitive potassium channel opener (KATP channel opener or KATPCO)[1][2][6]. It induces relaxation of vascular smooth muscle by activating KATP channels, primarily by binding to sulfonylurea receptors SUR2A and SUR2B with high affinity (Kd of 17 nM and 3 nM, respectively)[1]. This mechanism leads to peripheral vasodilation, reduced blood pressure, and increased blood flow[2]. P1075 has been used as a research tool in cardiovascular studies and exhibits high potency (EC50 rat aorta relaxation = 7.5 nM)[1]. No approved clinical indications or marketed pharmaceutical products containing P1075 are known, and it is predominantly distributed by research chemical suppliers[1][6].

Other names
3-pyridinyl-guanidineN-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine2-cyano-1-tert-pentyl-3-(3-pyridyl)-guanidine
02

Targets

SUR2B (Sulfonylurea receptor 2B)SUR2A (ATP-binding cassette sub-family C member 9)KATP channel (ATP-sensitive potassium channel)

Beyond the preview

Go deeper on p1075.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p1075.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call